Cancer Targeting Therapies
Conventional and Advanced Perspectives
Series: Drugs and the Pharmaceutical Sciences;
- Publisher's listprice GBP 81.99
-
39 170 Ft (37 305 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 20% (cc. 7 834 Ft off)
- Discounted price 31 336 Ft (29 844 Ft + 5% VAT)
- Discount is valid until: 31 December 2025
Subcribe now and take benefit of a favourable price.
Subscribe
39 170 Ft
Availability
Estimated delivery time: Expected time of arrival: end of January 2026.
Not in stock at Prospero.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Edition number 1
- Publisher CRC Press
- Date of Publication 30 September 2023
- ISBN 9781032426259
- Binding Hardback
- No. of pages312 pages
- Size 254x178 mm
- Weight 760 g
- Language English
- Illustrations 2 Illustrations, black & white; 35 Illustrations, color; 1 Halftones, color; 2 Line drawings, black & white; 34 Line drawings, color; 28 Tables, black & white 500
Categories
Short description:
This volume in the popular series, Drugs and the Pharmaceutical Sciences, begins with the history of cancer treatment, carcinogens, and molecular mechanisms involved in cancer pathogenesis.
MoreLong description:
This volume in the popular series, Drugs and the Pharmaceutical Sciences, begins with the history of cancer treatment, carcinogens, and molecular mechanisms involved in cancer pathogenesis. It incudes conventional and advanced cancer therapies ranging from oral and parenteral preparations to advanced fabricated systems such as nanoparticles, liposomes, antibodies, aptamers, poly(amidoamine) and photodynamic therapies. The preparation and mechanisms of molecular targeting of cancer are presented and the authors focus on a diverse audience including undergraduates and research students.
Features
- Timely coverage of changes in process control technology for the phamaceutical industry, a dynamic area in terms of products and manufacturing processes
- Provides an update on the unique requirements of these industries and how they differ from others, for example the microelectronics or specialized chemicals industries
- Draws on the author's vast experience in the field of industrial hygiene and hazardous materials
- Presents a collection of unique situations in which industrial hygiene was implemented to resolve a variety of scenarios and did not interfere with quality issues
- Addresses current topics relating to industry evolution such as migration of therapies to higher potency, RiskMAP, new modalities in medicines and treatments, large molecule therapeutics and conjugates
Table of Contents:
- History of Cancer Therapies
- Cancer and Carcinogens
- Causes of Death from Cancer
- Passive Targeting
- Cancer Active Targeting Strategies
- Oral Anticancer Therapies
- Parenteral Anticancer Therapies
- The Advent of Micro and Nano-spheres for Cancer Treatment
- The Emergence of Liposomes in Cancer Therapy
- Niosomes-Based Anticancer Therapies
- Solid Lipid Nanoparticles-Based Anticancer Therapies
- Mesoporous Nanoparticles-Based Anticancer Therapies
- Antibody-Based Cancer Therapies
- Aptamer-Based Anticancer Therapies
- Polyamidoamines-Based Anticancer Therapies
- Photodynamic Therapies for Cancer Treatment
Conventional Cancer Therapies
Advanced Cancer Therapies
